Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
McKesson
Baxter
Colorcon
Mallinckrodt

Last Updated: May 21, 2022

Radiomedix Company Profile


✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for RADIOMEDIX, and what generic alternatives to RADIOMEDIX drugs are available?

RADIOMEDIX has one approved drug.

There are three US patents protecting RADIOMEDIX drugs.

There are seven patent family members on RADIOMEDIX drugs in six countries.

Summary for Radiomedix
International Patents:7
US Patents:3
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Radiomedix

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Radiomedix DETECTNET copper dotatate cu-64 SOLUTION;INTRAVENOUS 213227-001 Sep 3, 2020 RX Yes Yes 11,160,888 See Plans and Pricing See Plans and Pricing
Radiomedix DETECTNET copper dotatate cu-64 SOLUTION;INTRAVENOUS 213227-001 Sep 3, 2020 RX Yes Yes 10,159,759 See Plans and Pricing See Plans and Pricing
Radiomedix DETECTNET copper dotatate cu-64 SOLUTION;INTRAVENOUS 213227-001 Sep 3, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing
Radiomedix DETECTNET copper dotatate cu-64 SOLUTION;INTRAVENOUS 213227-001 Sep 3, 2020 RX Yes Yes 10,383,961 See Plans and Pricing See Plans and Pricing
Radiomedix DETECTNET copper dotatate cu-64 SOLUTION;INTRAVENOUS 213227-001 Sep 3, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for Radiomedix Drugs

Country Patent Number Estimated Expiration
European Patent Office 2750717 See Plans and Pricing
World Intellectual Property Organization (WIPO) 2013029616 See Plans and Pricing
Denmark 2750717 See Plans and Pricing
Poland 2750717 See Plans and Pricing
European Patent Office 3536346 See Plans and Pricing
Poland 3536346 See Plans and Pricing
Spain 2732823 See Plans and Pricing
>Country >Patent Number >Estimated Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Moodys
Baxter
Express Scripts
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.